Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:
“A Proud Global Achievement for Nexomic !
We are proud to lead Nexomic and our exceptional team of scientists and researchers as we celebrate winning the AI Innovation of the Year Award at the prestigious Precision Medicine by Oxford Global, organized by the UK-based Oxford Global.
Kudos to my co-founders of Nexomic, Dr. Mohammad J. Ghosheh, Dr.Ghadeer Ghosheh, for their dedication and commitment to advance Nexomic progress.
This achievement is particularly significant as it marks the inaugural edition of these global awards, making Nexomic the first-ever recipient of the AI Innovation of the Year Award.
We are especially honored to be recognized alongside some of the world’s leading institutions and organizations, including Roche, Johnson & Johnson, the University of Oxford, ETH Zürich, and Cancer Research UK (CRUK), each recognized across different award categories.
This recognition is more than an award.
It is a testament to the exceptional talent, scientific excellence, and innovative capabilities of our Nexomic team to compete and lead on the global stage, helping shape the future of precision medicine through artificial intelligence.
I am incredibly proud of our scientists and researchers, what we have accomplished together, and, more importantly, what we aspire to achieve next – from the UAE to the world.
At Nexomic – We Understand Cancer Biology!”